236 related articles for article (PubMed ID: 11776131)
41. Thrombospondin binding by parasitized erythrocyte isolates in falciparum malaria.
Sherwood JA; Roberts DD; Marsh K; Harvey EB; Spitalnik SL; Miller LH; Howard RJ
Am J Trop Med Hyg; 1987 Mar; 36(2):228-33. PubMed ID: 3548449
[TBL] [Abstract][Full Text] [Related]
42. Plasmodium falciparum cytoadherence.
Leech J
Res Immunol; 1991 Oct; 142(8):681-6. PubMed ID: 1817298
[No Abstract] [Full Text] [Related]
43. Plasmodium coatneyi-infected rhesus monkeys: a primate model for human cerebral malaria.
Aikawa M; Brown AE; Smith CD; Tegoshi T; Howard RJ; Hasler TH; Ito Y; Collins WE; Webster HK
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():443-7. PubMed ID: 1343725
[TBL] [Abstract][Full Text] [Related]
44. Plasmodium falciparum erythrocyte membrane protein 1 variants induce cell swelling and disrupt the blood-brain barrier in cerebral malaria.
Adams Y; Olsen RW; Bengtsson A; Dalgaard N; Zdioruk M; Satpathi S; Behera PK; Sahu PK; Lawler SE; Qvortrup K; Wassmer SC; Jensen ATR
J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33492344
[TBL] [Abstract][Full Text] [Related]
45. Treatment of cerebral malaria by erythrocyte exchange.
Sighinolfi L; Libanore M; Bicocchi R; Reverberi R; Bedetti A; Ghinelli F
Recenti Prog Med; 1990 Dec; 81(12):804-5. PubMed ID: 2075285
[TBL] [Abstract][Full Text] [Related]
46. Acetylcholinesterase activities in cerebrospinal fluid of patients with Plasmodium falciparum cerebral malaria.
Areekul S; Churdchu K; Yamarat P
Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):431-4. PubMed ID: 3913001
[TBL] [Abstract][Full Text] [Related]
47. IgG autoantibody to brain beta tubulin III associated with cytokine cluster-II discriminate cerebral malaria in central India.
Bansal D; Herbert F; Lim P; Deshpande P; Bécavin C; Guiyedi V; de Maria I; Rousselle JC; Namane A; Jain R; Cazenave PA; Mishra GC; Ferlini C; Fesel C; Benecke A; Pied S
PLoS One; 2009 Dec; 4(12):e8245. PubMed ID: 20011600
[TBL] [Abstract][Full Text] [Related]
48. Cerebral Malaria and Neuronal Implications of Plasmodium Falciparum Infection: From Mechanisms to Advanced Models.
Akide Ndunge OB; Kilian N; Salman MM
Adv Sci (Weinh); 2022 Dec; 9(36):e2202944. PubMed ID: 36300890
[TBL] [Abstract][Full Text] [Related]
49. Plasmodium falciparum-infected erythrocytes induce tissue factor expression in endothelial cells and support the assembly of multimolecular coagulation complexes.
Francischetti IM; Seydel KB; Monteiro RQ; Whitten RO; Erexson CR; Noronha AL; Ostera GR; Kamiza SB; Molyneux ME; Ward JM; Taylor TE
J Thromb Haemost; 2007 Jan; 5(1):155-65. PubMed ID: 17002660
[TBL] [Abstract][Full Text] [Related]
50. Cerebrospinal fluid folate activity in patients with Plasmodium falciparum cerebral malaria.
Areekul S; Cheeramakara C
Trop Geogr Med; 1985 Sep; 37(3):227-30. PubMed ID: 3907060
[TBL] [Abstract][Full Text] [Related]
51. Identification of isolate-specific proteins on sorbitol-enriched Plasmodium falciparum infected erythrocytes from Gambian patients.
Aley SB; Sherwood JA; Marsh K; Eidelman O; Howard RJ
Parasitology; 1986 Jun; 92 ( Pt 3)():511-25. PubMed ID: 3526259
[TBL] [Abstract][Full Text] [Related]
52. TLRs innate immunereceptors and Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) CIDR1α-driven human polyclonal B-cell activation.
Simone O; Bejarano MT; Pierce SK; Antonaci S; Wahlgren M; Troye-Blomberg M; Donati D
Acta Trop; 2011 Aug; 119(2-3):144-50. PubMed ID: 21620790
[TBL] [Abstract][Full Text] [Related]
53. [Seroepidemiologic study of a focus of malaria in a non-endemic zone].
Pividal Grana J; Mesa Valiente LD; Machín Sánchez R; Fachado Carvajales A; Hernández Alvarez H; Garrido Lorente N
Rev Cubana Med Trop; 1987; 39(2):7-13. PubMed ID: 3321236
[No Abstract] [Full Text] [Related]
54. Human cerebral malaria.
Aikawa M
Am J Trop Med Hyg; 1988 Jul; 39(1):3-10. PubMed ID: 3041856
[TBL] [Abstract][Full Text] [Related]
55. Malian adults maintain serologic responses to virulent PfEMP1s amid seasonal patterns of fluctuation.
Ventimiglia NT; Stucke EM; Coulibaly D; Berry AA; Lyke KE; Laurens MB; Bailey JA; Adams M; Niangaly A; Kone AK; Takala-Harrison S; Kouriba B; Doumbo OK; Felgner PL; Plowe CV; Thera MA; Travassos MA
Sci Rep; 2021 Jul; 11(1):14401. PubMed ID: 34257318
[TBL] [Abstract][Full Text] [Related]
56. Studies on ATP level in erythrocytes of patients with Plasmodium falciparum malaria.
Areekul S; Charoenlarp P; Matrakul D; Sookprasert A; Ukoskit K
J Med Assoc Thai; 1975 Aug; 58(8):397-403. PubMed ID: 1099162
[No Abstract] [Full Text] [Related]
57. Adult cerebral malaria in Zambia: preliminary report of clinical findings and treatment response.
Olweny CL; Chauhan SS; Simooya OO; Bulsara MK; Njelesani EK; Van Thuc H
J Trop Med Hyg; 1986 Jun; 89(3):123-9. PubMed ID: 3534282
[TBL] [Abstract][Full Text] [Related]
58. Malaria: becoming more specific about non-specific immunity.
Kwiatkowski D
Curr Opin Immunol; 1992 Aug; 4(4):425-31. PubMed ID: 1388844
[TBL] [Abstract][Full Text] [Related]
59. Cerebrospinal fluid Plasmodium falciparum histidine-rich protein-2 in pediatric cerebral malaria.
Thakur KT; Vareta J; Carson KA; Kampondeni S; Potchen MJ; Birbeck GL; MacCormick I; Taylor T; Sullivan DJ; Seydel KB
Malar J; 2018 Mar; 17(1):125. PubMed ID: 29566695
[TBL] [Abstract][Full Text] [Related]
60. Intravenous immunoglobulin in the treatment of paediatric cerebral malaria.
Taylor TE; Molyneux ME; Wirima JJ; Borgstein A; Goldring JD; Hommel M
Clin Exp Immunol; 1992 Dec; 90(3):357-62. PubMed ID: 1458672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
